Episode Details

Back to Episodes
Pharmaceutical Executive Daily: FDA Approves Zanvastro

Pharmaceutical Executive Daily: FDA Approves Zanvastro

Published 2 months, 2 weeks ago
Description
Ionis wins FDA approval for Zanvastro, the first disease-modifying treatment for Alexander disease, Pharmaceutical Executive’s weekly biotech roundup gathers analyst reaction to the week's biggest stories, and Nate Hill of Strive Pharmacy talks through the regulatory uncertainty around compounded peptides.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us